Events
No upcoming Events!
Currently, we do not have any upcoming events. However, we are actively planning new events. Stay tuned for updates, as we will be announcing our upcoming events here on our website soon.To ensure you don’t miss any announcements, please sign up for our newsletter. You'll receive the latest news and updates about our events directly in your inbox.
News
March 2026
€7.5 million fresh capital to advance first-in-human studies and accelerate market entryWe are very pleased to announce that we have reached another milestone in the establishment of our Therapy Assistance CT, securing €5 million in venture capital and €2.5 million in EIC Accelerator funding. Dr. Thomas Hoffmann, CEO and co-founder ...
November 2024
RAYDIAX won Saxony-Anhalt Business Award 2024 It is a great honor for us to have won the Saxony-Anhalt Business Award 2024 in the start-up category.This award is an extraordinary recognition for us as a team and our efforts to further strengthen interventional oncology and make a positive ...
September 2024
RAYDIAX sponsors and participates at VCBM 2024We had the incredible opportunity to sponsor and participate in this year's 14th EG Symposium on Visual Computing for Biology and Medicine (VCBM 2024) conference. It was an absolute pleasure to welcome attendees to our booth and showcase...
September 2024
RAYDIAX recognized at Startup Germany SummitWe’re honored to have been recognized at the Startup Germany Summit! RAYDIAX is proud to have been named one of the 16 winners representing each federal state, awarded by Dr. Robert Habeck, Federal Minister for Economic Affairs and Climate Action..
February 2024
Economic boost from scienceRAYDIAX, as a company that emerged from a #science #transfer from the Forschungscampus STIMULATE / Otto-von-Guericke-Universität Magdeburg and is financed by private and institutional investors, is a #sparring #partner for new start-up initiatives...
December 2023
RAYDIAX and the STIMULATE research campus institutionalize long-term partnershipWe are happy to announce our newest long-term partnership together with the Forschungscampus STIMULATE to deepen the clinical and technical. Together we will work on innovative research topics relating to minimally invasive therapies...
October 2023
€3.5 million fresh capital for pre-clinical prototype and business growthWe are very pleased to announce that we have reached another milestone in the establishment of our Therapy Assistance CT.
Dr. Thomas Hoffmann, CEO and co-founder of RAYDIAX: "We pursue the...
April 2023
StreitBAR 2023 MagdeburgAm 20.04. hatten wir die Gelegenheit gemeinsam mit dem Präsidenten des Leibniz-Instituts für Wirtschaftsforschung Halle Prof. Dr. Reint Gropp, dem Rektor der Otto-von-Guericke-Universität Magdeburg Prof. Dr.-Ing. Jens ...
January 2023
Magdeburg mayor visited RAYDIAXGenerating economic effects by translating research results into clinical application is the key to sustainable medical technology. To convince herself of this, the mayor of Magdeburg Simone Borris visited RAYDIAX today. Our goal is to further exp...
August 2022
RAYDIAX presented to Olaf ScholzAs part of the STIMULATE research campus, we presented our science spin-off RAYDIAX to German chancellor Olaf Scholz yesterday. In the conversation, we had the opportunity to explain insights into the technical development of our world's first the...
June 2022
RAYDIAX at STIMULATE-RetreatLast week we were part of the STIMULATE Retreat to create innovative ideas, concepts and technologies to further improve the outcome of minimally invasive therapies for patients and caregivers in the future!Clinicians from different departments pi...
June 2022
Networking & Student InformationThis week we followed the invitation from the Weinberg Campus Accelerator to their Startup Meetup event in Halle. We were delighted to connect with young startups, experienced founders and investors. Thank you for the interesting meet-up and the g...
March 2022
Foundation of the RAYDIAX GmbHWith the foundation of “RAYDIAX GmbH” we have reached another milestone. Over the next few years, we will build up the company to develop and launch the world's first therapy-assistance CT! RAYDIAX aim is to assist physicians by enabling safe, in...
March 2022
High-Tech Gründerfonds MedTech PitchdayYesterday we had the excellent opportunity to present our company to leading investors as one of the 11 selected startups out of more than 150 applications at the MedTech Pitch Day 2022.Many thanks for the organization to the team of the High-Tech...
December 2021
Thank you!It is time to say thank you for an eventful and turbulent year. We are pleased to have been able to start building our RAYDIAX company in 2021 to advance global cancer treatment with our TACT system. A particular “Thank You” goes to the German Fed...
December 2021
EXIST-Forschungstransfer 'Gründergespräch'We visited the EXIST 'Gründergespräch' to get experiences and knowledges about personell, recruiting and working law for startups.
December 2021
RAYDIAX at the RSNA in ChicagoRAYDIAX was present at RSNA in Chicago to get in touch with new partners.
November 2021
EXIST-Seminar 'Gründerteam'We were at the EXIST-Seminar 'Gründerteam' in Berlin and get in touch with other EXIST founded startup teams.
October 2021
Clinical Design VR EvaluationSneak Peak: Together with our clinical partner, we are evaluating the interaction concept of our TACT in virtual reality at the STIMULATE research campus.
Ready for Innovation?
We know that the methods of minimally invasive therapies continue to offer great potential for clinical innovation. Would you also like to establish your operating technique? Make a suggestion, define a joint project and research your case on our system in phantom studies. And of course we are open to clinical publications.
